Pharm prime vendor fleet

Ended Awarded Last action

Contract number
SPE2DU26F0M92
Awardee
Awarding agency
Obligated
$1,008

Award facts

Contract value 100% obligated
$1,007.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $1,007.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, on January 3, 2026. This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. The delivery order represents firm fixed-price procurement of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. No set-aside designation was applied to this award, indicating the contractor competed in unrestricted federal procurement.

DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals to military healthcare facilities worldwide, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceutical products spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceutical categories. The PPV-G GEN V program, a $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to provide efficient pharmaceutical supply chain management for Department of Defense medical operations. DMS Pharmaceutical Group's performance on this and numerous prior delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.

Quick answers

Who was awarded contract SPE2DU26F0M92?

SPE2DU26F0M92 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 3, 2026.

How much is contract SPE2DU26F0M92 worth?

The government has obligated $1,008 on SPE2DU26F0M92.

Is contract SPE2DU26F0M92 an order under another contract?

Yes. SPE2DU26F0M92 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.

Was contract SPE2DU26F0M92 competed?

The extent of competition for SPE2DU26F0M92 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award